Probióticos para el tratamiento del eccema
Información
- DOI:
- https://doi.org/10.1002/14651858.CD006135.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 08 octubre 2008see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Piel
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Link with editorial base and co‐ordinate contributions from co‐reviewers (RB)
Draft protocol (RB with contributions from all co‐reviewers)
Run search (RB)
Identify relevant titles and abstracts from searches (RB, MT)
Obtain copies of trials (RB)
Selection of trials (RB, MT)
Extract data from trials (RB, FB)
Enter data into RevMan (RB, FB)
Carry out analysis (RB, JL)
Interpret data (RB, MT, DM, FB)
Draft final review (RB, with contributions from all co‐reviewers)
Update review (RB)
Sources of support
Internal sources
-
Murdoch Children's Research Institute, Australia.
-
University of Melbourne, Australia.
-
Royal Children's Hospital, Australia.
-
Department of Paediatrics, Imperial College, London, UK.
External sources
-
No sources of support supplied
Declaraciones de interés
Ninguno conocido.
Agradecimientos
Se dan las gracias a Judy Taylor y George Varigos por sus contribuciones en la redacción del protocolo para esta revisión.
El Grupo Cochrane de la Piel (Cochrane Skin Group) agradece a Claudia Gore, Nerys Roberts y John Sinn (expertos de contenido externos), Shirley Manknell y Sharon Gudu (consumidores que actuaron como evaluadores externos). Los autores agradecen al Australasian Cochrane Centre la experiencia y asesoramiento con respecto a la compleción de esta revisión y a Damian Jolly el asesoramiento estadístico.
Version history
| Published | Title | Stage | Authors | Version |
| 2018 Nov 21 | Probiotics for treating eczema | Review | Areti Makrgeorgou, Jo Leonardi‐Bee, Fiona J Bath‐Hextall, Dedee F Murrell, Mimi LK Tang, Amanda Roberts, Robert J Boyle | |
| 2008 Oct 08 | Probiotics for treating eczema | Review | Robert John Boyle, Fiona J Bath‐Hextall, Jo Leonardi‐Bee, Dedee F Murrell, Mimi LK Tang | |
| 2006 Jul 19 | Probiotics for atopic eczema | Protocol | Robert John Boyle, Fiona J Bath‐Hextall, S Donath, Dedee F Murrell, Mimi LK Tang, Judy Taylor, George Varigos | |
Differences between protocol and review
We changed the title which was Probiotics for atopic eczema in the protocol to Probiotics for treating eczema on the advice of the referees.
We have made small changes to the Background on the advice of the referees.
We made small changes to the 'Criteria for considering studies for the review' to clarify issues
Data extraction was completed by RB and FB in the review, in place of RB and MT in the protocol due to time availability.
Dichotomous outcome data have been reported as OR in the review, and RR were planned in the protocol. This was due to the inclusion of a cross‐over trial in the review. It is not possible to pool the data from cross‐over and parallel group trials using the inverse generic variance method with RR, therefore OR have been used throughout this review to maximise the available data for meta‐analyses, and for consistency of interpretation.
Finally an extra subgroup analysis was undertaken in the review which had not been specified in the protocol ‐ outcome data were analysed according to the probiotic strain used Analysis 1.13. This analysis was undertaken due the unexplained heterogeneity between studies for primary and secondary outcomes, and the use of the same probiotic strain in several studies. As discussed above, conclusions from this analysis must be guarded due to its post‐hoc nature.
